NL-OMON41120已完成不适用
Development and validation of a pharmacokinetic model of flucloxacillin for dosing in patients with impaired renal function - PK-model Flucloxacillin
Atrium Medisch Centrum0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- adults treated with oral or intravenous flucloxacillin
- •- normal and impaired renal function expressed as MDRD and corrected for BSA (body surface area)
排除标准
- •- patients younger than 18 years of age;
- •- legally incapable patients;
- •- contra-indication or allergy to the treatment with flucloxacillin;
- •- pregnant patients;
- •- patients receiving dialysis.
研究者
相似试验
进行中（未招募）
不适用
Dexmedetomidine PKPD and effect of stimulatioEUCTR2012-005443-24-NLMCG
已完成
不适用
Development of a pharmacokinetic/pharmacodynamic model of dexmedetomidine, and the effect of repeated auditory stimulation on pharmacodynamics of dexmedetomidine.*gezonde vrijwilligers, dus geen aandoeningenpharmacodynamicPharmacokineticNL-OMON39625niversitair Medisch Centrum Groningen18
招募中
不适用
Validation of Pharmacokinetic and Pharmacodynamic Assays for determination of Nivolumab and Pembrolizumab concentrations, and the occupancy of their target receptor Programmed Death-1 (PD-1) on T-cellsmetastasized cancerSolid tumors10027476NL-OMON47401Antoni van Leeuwenhoek Ziekenhuis70
尚未招募
Unknown
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsTuberculosisACTRN12623001088639Western Sydney Local Health District30
已完成
不适用
A study to evaluate the Pharmacokinetics and Pharmacodynamics of tolvaptan in congestive heart failure patients with renal impairmentCongestive heart failureJPRN-UMIN000006859St. Marianna University Hospital18